USPTO Examiner ROBINSON NICHOLAS A - Art Unit 3798

Recent Applications

Detailed information about the 100 most recent patent applications.

Application NumberTitleFiling DateDisposal DateDispositionTime (months)Office ActionsRestrictionsInterviewAppeal
18614455METHODS AND APPARATUS FOR PERFORMING MEASUREMENTS ON AN ULTRASOUND IMAGEMarch 2024May 2025Allow1310YesNo
18387197SCANNING CONTROL SYSTEM AND METHOD FOR MAGNETIC RESONANCE IMAGING SYSTEMNovember 2023July 2024Allow810YesNo
18141450METHODS AND APPARATUS FOR PERFORMING MEASUREMENTS ON AN ULTRASOUND IMAGEApril 2023November 2023Allow700YesNo
18137568Magnet Arrangement for a Magnetic Resonance ApparatusApril 2023April 2025Abandon2310NoNo
18127462NEEDLE GUIDANCE DEVICE FOR ULTRASOUND PROBEMarch 2023March 2025Abandon2310NoNo
18174877ULTRASOUND CATHETERFebruary 2023April 2025Abandon2510NoNo
18171276USE OF NEUROMELANIN-SENSITIVE MRI AS A BIOMARKER OF DOPAMINE FUNCTIONFebruary 2023February 2025Abandon2410NoNo
18017889ARRANGEMENT AND METHOD FOR DETERMINING THE POSITION OF AN INVASIVE DEVICEJanuary 2023January 2025Allow2310YesNo
18017935HEART RATE DETECTION METHOD AND ELECTRONIC DEVICEJanuary 2023April 2025Allow2611YesNo
18005947Portable Handheld Magnetic Particle ImagingJanuary 2023February 2025Allow2510YesNo
18155217ULTRASONIC DIAGNOSTIC APPARATUS AND IMAGE PROCESSING APPARATUSJanuary 2023March 2025Allow2611YesNo
17978697CLUTTER REDUCTION FOR ULTRASOUND IMAGES AND ASSOCIATED DEVICES, SYSTEMS, AND METHODSNovember 2022November 2023Allow1320YesNo
18047555IMAGE GUIDANCE DURING CANNULATIONOctober 2022May 2025Allow3130YesNo
18046271SYMPTOM RECORDING APPARATUS, SYMPTOM RECORDING METHOD, AND PROGRAMOctober 2022December 2024Abandon2610NoNo
17908574IMAGING SYSTEM AND DEVICE FOR BREAST CANCER DETECTIONSeptember 2022October 2024Abandon2610NoNo
17842416TRACKING A FEATURE OF AN INTERVENTIONAL DEVICEJune 2022February 2024Allow2010YesNo
17739320MAGNETIC RESONANCE APPARATUS WITH A PATIENT POSITIONING APPARATUSMay 2022March 2024Abandon2220YesNo
17710069TRANSDUCER WITH ROTATABLE HEAD AND RECONFIGURABLE ARRAY CURVATUREMarch 2022March 2025Abandon3550YesNo
17687476Systems and Methods for Ultrasound-And-Bioimpedance-Based Guidance of Medical DevicesMarch 2022March 2025Allow3610YesNo
17638206SYNTHETIC FOUR-DIMENSIONAL COMPUTED TOMOGRAPHIC IMAGE GENERATIONFebruary 2022May 2024Allow2600YesNo
17636144SYSTEM AND METHOD FOR IDENTIFYING ERRORS IN POSITIONING OF A SUBJECT FOR CAPTURING A THERMAL IMAGEFebruary 2022March 2025Allow3711YesNo
17633527ULTRASOUND IMAGE-BASED DIAGNOSIS SYSTEM FOR CORONARY ARTERY LESION USING MACHINE LEARNING AND DIAGNOSIS METHOD OF SAMEFebruary 2022March 2025Abandon3720NoNo
17614607ENCODED SYNCHRONIZED MEDICAL INTERVENTION IMAGE SIGNALS AND SENSOR SIGNALSNovember 2021June 2025Abandon4320NoNo
17607240ULTRASONIC TRANSDUCEROctober 2021June 2024Abandon3230YesNo
17498636CLOSED CAVITY ADJUSTABLE SENSOR MOUNT SYSTEMS AND METHODSOctober 2021December 2023Allow2600YesNo
17493451METHOD AND DEVICE FOR CORRECTING OPTICAL SIGNALSOctober 2021March 2024Allow3000YesNo
17416712FLEXIBLE SENSORJune 2021December 2024Allow4230YesNo
17317256SYSTEM AND METHOD FOR TRAINING A REMOTE PHOTOPLETHYSMOGRAPHY MODELMay 2021March 2024Allow3400YesNo
17291951Instrumented Ultrasound Probes For Machine-Learning Generated Real-Time Sonographer FeedbackMay 2021April 2025Abandon4840YesNo
17288603DENTAL IMAGING SYSTEMApril 2021October 2024Abandon4220YesNo
17276500IMAGING SYSTEM WITH OPTICAL PATHWAYMarch 2021November 2024Allow4420YesNo
17266600INTERVENTIONAL DEVICE POSITIONING USING ULTRASOUND SIGNALSFebruary 2021April 2025Allow5140YesNo
17166057SINGLE SHIM COIL DESIGN FOR B0 SHIMMINGFebruary 2021January 2024Allow3611YesNo
17259294METHODS AND SYSTEMS FOR PERFORMING FETAL WEIGHT ESTIMATIONSJanuary 2021April 2024Allow3910YesNo
17103059METHODS AND APPARATUSES FOR PULSED WAVE DOPPLER ULTRASOUND IMAGINGNovember 2020February 2024Abandon3940NoNo
16953464DIAGNOSTIC METHOD, DIAGNOSTIC SYSTEM, AND CONTROL METHOD OF DIAGNOSTIC SYSTEMNovember 2020October 2024Allow4630YesNo
17087150SYSTEMS, APPARATUS, AND METHODS FOR DELIVERING A MEDICAL DEVICE BEYOND A BIFURCATION IN A BODY LUMENNovember 2020May 2025Abandon5430YesNo
17078301MEDICAL INFORMATION PROCESSING SYSTEM AND MEDICAL INFORMATION PROCESSING METHODOctober 2020February 2024Allow4041YesNo
17075103System And Method Of Signal Processing For Ultrasound Arrays With Mechanically Adjustable Transducer ShapesOctober 2020January 2024Allow3942NoNo
17070754SYSTEMS FOR AN ULTRASOUND SCAN TRAYOctober 2020March 2024Abandon4141YesNo
17067436ULTRASOUND ELASTOGRAPHY METHOD AND SYSTEMOctober 2020December 2024Allow5060YesNo
17031380INTRODUCER AND LOCALIZATION WIRE VISUALIZATIONSeptember 2020June 2024Allow4440YesNo
16982821METHOD FOR REAL-TIME MOTION MONITORING AND DOSE ACCUMULATION IN MAGNETIC RESONANCE GUIDED THERAPIES USING SIMULTANEOUS ORTHOGONAL PLANE IMAGINGSeptember 2020April 2024Allow4310YesNo
16967327FORCE SENSOR, AND ELECTROPHYSIOLOGY CATHETERAugust 2020March 2025Abandon5540NoNo
16926055REPRESENTATION OF A TARGET DURING AIMING OF AN ULTRASOUND PROBEJuly 2020January 2024Allow4250YesNo
16755315Use of Ultrasound to Guide Injection of Non-cytotoxic ProteaseApril 2020April 2024Abandon4842YesNo
16843762Assemblies for Identifying a Power Injectable Access PortApril 2020March 2024Abandon4710YesNo
16829546DEVICE, METHOD, AND PROGRAM FOR VISUALIZING NETWORK OF BLOOD VESSELS OF SKINMarch 2020August 2024Allow5370YesNo
16801835ULTRASOUND IMAGING SYSTEM AND INTERVENTIONAL MEDICAL DEVICE FOR USE THEREWITHFebruary 2020October 2023Allow4451YesNo
16747203SYSTEMS FOR AN ULTRASOUND SCAN TRAYJanuary 2020August 2024Abandon5551NoNo
16689408ANKLE COILNovember 2019January 2024Abandon4940YesNo
16681408HISTORICAL ULTRASOUND DATA FOR DISPLAY OF LIVE LOCATION DATANovember 2019December 2024Allow6041YesNo
16492082COMPOSITION FOR REMOVING NOISE FROM MRI AND PAD USING THE SAMESeptember 2019February 2025Abandon6060NoNo
16489423FLEXIBLE CONTROL AND GUIDANCE OF MINIMALLY INVASIVE FOCUSED ULTRASOUNDAugust 2019May 2024Abandon5660YesNo
16517862ULTRASOUND SIGNAL PROCESSING DEVICE, ULTRASOUND DIAGNOSTIC DEVICE, AND ULTRASOUND SIGNAL PROCESSING METHODJuly 2019April 2024Allow5750YesNo
16343223INNER MEMBER FOR INTRAVASCULAR IMAGING DEVICE AND ASSOCIATED DEVICES, SYSTEMS, AND METHODSApril 2019January 2024Abandon5760YesNo
16376636IMAGE-BASED NAVIGATION SYSTEM AND METHOD OF USING SAMEApril 2019April 2025Allow6080YesYes
16338113SIGNAL PROCESSING PATHWAY FOR AN ULTRASONIC IMAGING DEVICEMarch 2019December 2024Allow6061YesYes
16357127SYSTEMS AND METHODS FOR ULTRASOUND MODULATION OF NEURONSMarch 2019February 2024Abandon5941YesNo
16329608QUANTITATIVE DIFFERENTIATION OF TUMOR HETEROGENEITY USING DIFFUSION MR IMAGING DATAFebruary 2019February 2024Allow6050YesNo
16313862IMPLANTS USING ULTRASONIC BACKSCATTER FOR DETECTING ELECTROPHYSIOLOGICAL SIGNALSDecember 2018May 2025Abandon6051YesNo
16197762OPTOACOUSTIC PROBENovember 2018December 2024Allow6041NoYes
16303212Skin Inspection Device for Identifying AbnormalitiesNovember 2018March 2025Allow6080YesNo
16165604ACCELEROMETER IN HANDLE FOR ULTRASOUND MEDICAL IMAGING DEVICEOctober 2018December 2024Abandon6081YesNo
16128197ROBOTIC LIGHT PROJECTION TOOLSSeptember 2018April 2024Abandon6071YesNo
15766327Systems and methods for ultrasound elastography with continuous transducer vibrationApril 2018February 2024Allow6061YesNo

Appeals Overview

This analysis examines appeal outcomes and the strategic value of filing appeals for examiner ROBINSON, NICHOLAS A.

Patent Trial and Appeal Board (PTAB) Decisions

Total PTAB Decisions
1
Examiner Affirmed
0
(0.0%)
Examiner Reversed
1
(100.0%)
Reversal Percentile
99.9%
Higher than average

What This Means

With a 100.0% reversal rate, the PTAB has reversed the examiner's rejections more often than affirming them. This reversal rate is in the top 25% across the USPTO, indicating that appeals are more successful here than in most other areas.

Strategic Value of Filing an Appeal

Total Appeal Filings
4
Allowed After Appeal Filing
3
(75.0%)
Not Allowed After Appeal Filing
1
(25.0%)
Filing Benefit Percentile
94.2%
Higher than average

Understanding Appeal Filing Strategy

Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.

In this dataset, 75.0% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is in the top 25% across the USPTO, indicating that filing appeals is particularly effective here. The act of filing often prompts favorable reconsideration during the mandatory appeal conference.

Strategic Recommendations

Appeals to PTAB show good success rates. If you have a strong case on the merits, consider fully prosecuting the appeal to a Board decision.

Filing a Notice of Appeal is strategically valuable. The act of filing often prompts favorable reconsideration during the mandatory appeal conference.

Examiner ROBINSON, NICHOLAS A - Prosecution Strategy Guide

Executive Summary

Examiner ROBINSON, NICHOLAS A works in Art Unit 3798 and has examined 65 patent applications in our dataset. With an allowance rate of 56.9%, this examiner allows applications at a lower rate than most examiners at the USPTO. Applications typically reach final disposition in approximately 42 months.

Allowance Patterns

Examiner ROBINSON, NICHOLAS A's allowance rate of 56.9% places them in the 11% percentile among all USPTO examiners. This examiner is less likely to allow applications than most examiners at the USPTO.

Office Action Patterns

On average, applications examined by ROBINSON, NICHOLAS A receive 3.17 office actions before reaching final disposition. This places the examiner in the 97% percentile for office actions issued. This examiner issues more office actions than most examiners, which may indicate thorough examination or difficulty in reaching agreement with applicants.

Prosecution Timeline

The median time to disposition (half-life) for applications examined by ROBINSON, NICHOLAS A is 42 months. This places the examiner in the 5% percentile for prosecution speed. Applications take longer to reach final disposition with this examiner compared to most others.

Interview Effectiveness

Conducting an examiner interview provides a +54.3% benefit to allowance rate for applications examined by ROBINSON, NICHOLAS A. This interview benefit is in the 96% percentile among all examiners. Recommendation: Interviews are highly effective with this examiner and should be strongly considered as a prosecution strategy. Per MPEP § 713.10, interviews are available at any time before the Notice of Allowance is mailed or jurisdiction transfers to the PTAB.

Request for Continued Examination (RCE) Effectiveness

When applicants file an RCE with this examiner, 14.5% of applications are subsequently allowed. This success rate is in the 5% percentile among all examiners. Strategic Insight: RCEs show lower effectiveness with this examiner compared to others. Consider whether a continuation application might be more strategic, especially if you need to add new matter or significantly broaden claims.

After-Final Amendment Practice

This examiner enters after-final amendments leading to allowance in 2.0% of cases where such amendments are filed. This entry rate is in the 1% percentile among all examiners. Strategic Recommendation: This examiner rarely enters after-final amendments compared to other examiners. You should generally plan to file an RCE or appeal rather than relying on after-final amendment entry. Per MPEP § 714.12, primary examiners have discretion in entering after-final amendments, and this examiner exercises that discretion conservatively.

Appeal Withdrawal and Reconsideration

This examiner withdraws rejections or reopens prosecution in 75.0% of appeals filed. This is in the 63% percentile among all examiners. Strategic Insight: This examiner shows above-average willingness to reconsider rejections during appeals. The mandatory appeal conference (MPEP § 1207.01) provides an opportunity for reconsideration.

Petition Practice

When applicants file petitions regarding this examiner's actions, 166.7% are granted (fully or in part). This grant rate is in the 99% percentile among all examiners. Strategic Note: Petitions are frequently granted regarding this examiner's actions compared to other examiners. Per MPEP § 1002.02(c), various examiner actions are petitionable to the Technology Center Director, including prematureness of final rejection, refusal to enter amendments, and requirement for information. If you believe an examiner action is improper, consider filing a petition.

Examiner Cooperation and Flexibility

Examiner's Amendments: This examiner makes examiner's amendments in 0.0% of allowed cases (in the 45% percentile). This examiner makes examiner's amendments less often than average. You may need to make most claim amendments yourself.

Quayle Actions: This examiner issues Ex Parte Quayle actions in 0.0% of allowed cases (in the 44% percentile). This examiner issues Quayle actions less often than average. Allowances may come directly without a separate action for formal matters.

Prosecution Strategy Recommendations

Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:

  • Prepare for rigorous examination: With a below-average allowance rate, ensure your application has strong written description and enablement support. Consider filing a continuation if you need to add new matter.
  • Expect multiple rounds of prosecution: This examiner issues more office actions than average. Address potential issues proactively in your initial response and consider requesting an interview early in prosecution.
  • Prioritize examiner interviews: Interviews are highly effective with this examiner. Request an interview after the first office action to clarify issues and potentially expedite allowance.
  • Plan for RCE after final rejection: This examiner rarely enters after-final amendments. Budget for an RCE in your prosecution strategy if you receive a final rejection.
  • Plan for extended prosecution: Applications take longer than average with this examiner. Factor this into your continuation strategy and client communications.

Relevant MPEP Sections for Prosecution Strategy

  • MPEP § 713.10: Examiner interviews - available before Notice of Allowance or transfer to PTAB
  • MPEP § 714.12: After-final amendments - may be entered "under justifiable circumstances"
  • MPEP § 1002.02(c): Petitionable matters to Technology Center Director
  • MPEP § 1004: Actions requiring primary examiner signature (allowances, final rejections, examiner's answers)
  • MPEP § 1207.01: Appeal conferences - mandatory for all appeals
  • MPEP § 1214.07: Reopening prosecution after appeal

Important Disclaimer

Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.

No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.

Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.

Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.